{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:44:24Z","timestamp":1777646664728,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"am","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bulcan.2020.10.014","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T00:07:41Z","timestamp":1608854861000},"page":"90-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Vaccination contre le virus de l\u2019h\u00e9patite B et pr\u00e9vention du cancer du foie"],"prefix":"10.1016","volume":"108","author":[{"given":"Fanny","family":"Leboss\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2020.10.014_bib0405","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"issue":"8256","key":"10.1016\/j.bulcan.2020.10.014_bib0410","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707\u00a0men in Taiwan","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.bulcan.2020.10.014_bib0415","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.bulcan.2020.10.014_bib0420","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S2468-1253(19)30042-1","article-title":"Hepatitis B virus infection in children and adolescents","volume":"4","author":"Indolfi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9959","key":"10.1016\/j.bulcan.2020.10.014_bib0425","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.bulcan.2020.10.014_bib0430","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primer"},{"issue":"5\u00a0Suppl","key":"10.1016\/j.bulcan.2020.10.014_bib0435","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: the virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatol Baltim Md"},{"issue":"2","key":"10.1016\/j.bulcan.2020.10.014_bib0440","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"European Association for the Study of the Liver. EASL 2017\u00a0Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.10.014_bib0445","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","article-title":"Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma","volume":"13","author":"Arzumanyan","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2020.10.014_bib0450","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/gutjnl-2013-306228","article-title":"Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas","volume":"64","author":"Amaddeo","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bulcan.2020.10.014_bib0455","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bulcan.2020.10.014_bib0460","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"issue":"1\u00a0Suppl","key":"10.1016\/j.bulcan.2020.10.014_bib0465","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J Hepatol"},{"issue":"5\u00a0Suppl 1","key":"10.1016\/j.bulcan.2020.10.014_bib0470","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1053\/j.gastro.2004.09.016","article-title":"Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms","volume":"127","author":"Br\u00e9chot","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bulcan.2020.10.014_bib0475","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1073\/pnas.91.6.2230","article-title":"Hepatitis B virus X protein inhibits p53\u00a0sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3","volume":"91","author":"Wang","year":"1994","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.bulcan.2020.10.014_bib0480","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jhep.2009.10.033","article-title":"Mechanisms of HBV-related hepatocarcinogenesis","volume":"52","author":"Neuveut","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.bulcan.2020.10.014_bib0485","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fgene.2018.00261","article-title":"Host and viral genetic variation in HBV-related hepatocellular carcinoma","volume":"9","author":"An","year":"2018","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.bulcan.2020.10.014_bib0490","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.28115","article-title":"Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy","volume":"62","author":"Jung","year":"2015","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.bulcan.2020.10.014_bib0495","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bulcan.2020.10.014_bib0500","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jhep.2018.07.018","article-title":"Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy","volume":"69","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.bulcan.2020.10.014_bib0505","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.10.014_bib0510","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2020.02.030","article-title":"Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"73","author":"Alfaiate","year":"2020","journal-title":"J Hepato"},{"issue":"4","key":"10.1016\/j.bulcan.2020.10.014_bib0515","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"issue":"7974","key":"10.1016\/j.bulcan.2020.10.014_bib0520","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(76)93023-3","article-title":"Immunisation against hepatitis B in man","volume":"1","author":"Maupas","year":"1976","journal-title":"Lancet Lond Engl"},{"issue":"15","key":"10.1016\/j.bulcan.2020.10.014_bib0525","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States","volume":"303","author":"Szmuness","year":"1980","journal-title":"N Engl J Med"},{"issue":"8215","key":"10.1016\/j.bulcan.2020.10.014_bib0530","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(81)91908-5","article-title":"Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal)","volume":"1","author":"Maupas","year":"1981","journal-title":"Lancet Lond Engl"},{"issue":"1\u20132","key":"10.1016\/j.bulcan.2020.10.014_bib0535","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0264-410X(99)00179-6","article-title":"Over a decade of experience with a yeast recombinant hepatitis B vaccine","volume":"18","author":"Assad","year":"1999","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.bulcan.2020.10.014_bib0540","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00003495-200363100-00006","article-title":"Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B","volume":"63","author":"Keating","year":"2003","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.bulcan.2020.10.014_bib0545","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1073\/pnas.79.2.579","article-title":"Hepatitis B virus vaccine: identification of HBsAg\/a and HBsAg\/d but not HBsAg\/y subtype antigenic determinants on a synthetic immunogenic peptide","volume":"79","author":"Prince","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1016\/j.bulcan.2020.10.014_bib0550","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.3748\/wjg.v20.i24.7653","article-title":"Clinical implications of hepatitis B virus mutations: recent advances","volume":"20","author":"Lazarevic","year":"2014","journal-title":"World J Gastroenterol WJG"},{"issue":"2","key":"10.1016\/j.bulcan.2020.10.014_bib0555","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.vaccine.2017.07.046","article-title":"Hepatitis B vaccines: WHO position paper, July 2017\u00a0\u2013\u00a0Recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.bulcan.2020.10.014_bib0560","unstructured":"Recommandations HAS. Calendrier vaccinal Mars 2019 [Internet]. Disponible sur: https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/calendrier_vaccinal_mars_2019.pdf."},{"issue":"18","key":"10.1016\/j.bulcan.2020.10.014_bib0565","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.vaccine.2018.03.044","article-title":"Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: protective anti-HBs levels and cellular immune responses","volume":"36","author":"Li","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.bulcan.2020.10.014_bib0570","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(83)90005-1","article-title":"Immunogenicity of HBV vaccine in healthy Chinese children","volume":"1","author":"Hwang","year":"1983","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.bulcan.2020.10.014_bib0575","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0264-410X(95)00209-J","article-title":"Immune response to a booster dose of enhanced potency inactivated polio vaccine administered in association with HBV vaccine in adolescents","volume":"14","author":"Pregliasco","year":"1996","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.bulcan.2020.10.014_bib0580","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.4161\/hv.29617","article-title":"Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9\u201310-year-old girls according to 0\u20136\u00a0month schedule","volume":"10","author":"Gilca","year":"2014","journal-title":"Hum Vaccines Immunother"},{"issue":"19","key":"10.1016\/j.bulcan.2020.10.014_bib0585","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0264-410X(99)00529-0","article-title":"Study of the safety, immunogenicity and seroconversion of a hepatitis-B vaccine in malnourished children of India","volume":"18","author":"Lakshmi","year":"2000","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.bulcan.2020.10.014_bib0590","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0264-410X(99)00394-1","article-title":"The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection","volume":"18","author":"Gregorek","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.bulcan.2020.10.014_bib0595","first-page":"1108","article-title":"Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults","volume":"11","author":"Li","year":"2015","journal-title":"Hum Vaccines Immunother"},{"issue":"11","key":"10.1016\/j.bulcan.2020.10.014_bib0600","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/344271","article-title":"The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis","volume":"35","author":"Fisman","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.bulcan.2020.10.014_bib0605","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jmv.1890350313","article-title":"A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls","volume":"35","author":"Wismans","year":"1991","journal-title":"J Med Virol"},{"issue":"24","key":"10.1016\/j.bulcan.2020.10.014_bib0610","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1001\/jama.1993.03510240047030","article-title":"Risk Factors for Lack of Detectable Antibody Following Hepatitis B Vaccination of Minnesota Health Care Workers","volume":"270","author":"Wood","year":"1993","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bulcan.2020.10.014_bib0615","doi-asserted-by":"crossref","first-page":"e58029","DOI":"10.1371\/journal.pone.0058029","article-title":"Observational study of vaccine efficacy 24\u00a0years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose","volume":"8","author":"Mendy","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.bulcan.2020.10.014_bib0620","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/345871","article-title":"Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan","volume":"187","author":"Lin","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.bulcan.2020.10.014_bib0625","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/21645515.2018.1509658","article-title":"Long-term antibody persistence against hepatitis B in adolescents 14\u201315\u00a0years of age vaccinated with 4\u00a0doses of hexavalent DTPa-HBV-IPV\/Hib vaccine in infancy","volume":"15","author":"Schwarz","year":"2019","journal-title":"Hum Vaccines Immunother"},{"issue":"44","key":"10.1016\/j.bulcan.2020.10.014_bib0630","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1016\/j.vaccine.2011.07.098","article-title":"Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination","volume":"29","author":"Zhu","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.bulcan.2020.10.014_bib0635","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jmv.24506","article-title":"The efficacy of hepatitis B vaccination program in upper Egypt: flow cytometry and the evaluation of long term immunogenicity","volume":"88","author":"Makhlouf","year":"2016","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.bulcan.2020.10.014_bib0640","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.vaccine.2011.01.025","article-title":"Antibody levels and immune memory 23\u00a0years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high","volume":"29","author":"Wu","year":"2011","journal-title":"Vaccine"},{"issue":"9203","key":"10.1016\/j.bulcan.2020.10.014_bib0645","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(99)02991-8","article-title":"School-based hepatitis B vaccination programme and adolescent multiple sclerosis","volume":"355","author":"Sadovnick","year":"2000","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"10.1016\/j.bulcan.2020.10.014_bib0650","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","article-title":"Hepatitis B vaccination and the risk of multiple sclerosis","volume":"344","author":"Ascherio","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bulcan.2020.10.014_bib0655","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","article-title":"Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases","volume":"71","author":"Langer-Gould","year":"2014","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.bulcan.2020.10.014_bib0660","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.vaccine.2018.02.036","article-title":"Hepatitis B vaccination and the putative risk of central demyelinating diseases\u00a0\u2013\u00a0A systematic review and meta-analysis","volume":"36","author":"Mouchet","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.bulcan.2020.10.014_bib0665","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1086\/314585","article-title":"Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization","volume":"179","author":"Hsu","year":"1999","journal-title":"J Infect Dis"},{"issue":"47","key":"10.1016\/j.bulcan.2020.10.014_bib0670","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of Hepatitis B in China\u00a0\u2013\u00a0Declining HBV prevalence due to Hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.bulcan.2020.10.014_bib0675","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.vaccine.2013.11.004","article-title":"A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination","volume":"32","author":"Nguyen","year":"2014","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.bulcan.2020.10.014_bib0680","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1016\/j.vaccine.2019.06.073","article-title":"Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017","volume":"37","author":"Ork","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.bulcan.2020.10.014_bib0685","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-14-7","article-title":"Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986\u20131990) and in the nationwide immunisation program","volume":"14","author":"Peto","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.bulcan.2020.10.014_bib0690","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijid.2004.06.009","article-title":"Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria","volume":"9","author":"Odusanya","year":"2005","journal-title":"Int J Infect Dis IJID"},{"issue":"10","key":"10.1016\/j.bulcan.2020.10.014_bib0695","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/INF.0b013e31829be401","article-title":"Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization","volume":"32","author":"Rey-Cuille","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"34","key":"10.1016\/j.bulcan.2020.10.014_bib0700","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.vaccine.2017.06.078","article-title":"Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1\u00a0and 29years from 2006\u00a0to 2014","volume":"35","author":"Zhou","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.bulcan.2020.10.014_bib0705","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jhep.2015.03.013","article-title":"Slow decline of hepatitis B burden in general population: results from a population-based survey and longitudinal follow-up study in Taiwan","volume":"63","author":"Chen","year":"2015","journal-title":"J Hepatol"},{"issue":"50","key":"10.1016\/j.bulcan.2020.10.014_bib0710","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.1016\/j.vaccine.2012.09.033","article-title":"The end of the Australia antigen? An ecological study of the impact of universal newborn hepatitis B vaccination two decades on","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"issue":"6.","key":"10.1016\/j.bulcan.2020.10.014_bib0715","article-title":"Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union\/European Economic Area countries, 2006\u00a0to 2014","volume":"23","author":"Miglietta","year":"2018","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"issue":"24","key":"10.1016\/j.bulcan.2020.10.014_bib0720","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.3748\/wjg.v20.i24.7635","article-title":"Epidemiology of acute and chronic hepatitis B and delta over the last 5\u00a0decades in Italy","volume":"20","author":"Sagnelli","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.bulcan.2020.10.014_bib0725","doi-asserted-by":"crossref","first-page":"e0157161","DOI":"10.1371\/journal.pone.0157161","article-title":"Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia","volume":"11","author":"Klushkina","year":"2016","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.bulcan.2020.10.014_bib0730","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2471\/BLT.17.205153","article-title":"Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis","volume":"96","author":"Whitford","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.bulcan.2020.10.014_bib0735","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.bulcan.2020.10.014_bib0740","doi-asserted-by":"crossref","first-page":"e110143","DOI":"10.1371\/journal.pone.0110143","article-title":"The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology","volume":"9","author":"Goyal","year":"2014","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.bulcan.2020.10.014_bib0745","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"26","key":"10.1016\/j.bulcan.2020.10.014_bib0750","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bulcan.2020.10.014_bib0755","first-page":"507","article-title":"Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program","volume":"9","author":"Wichajarn","year":"2008","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"3","key":"10.1016\/j.bulcan.2020.10.014_bib0760","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/hep.24442","article-title":"Elimination of hepatocellular carcinoma and acute hepatitis B in children 25\u00a0years after a hepatitis B newborn and catch-up immunization program","volume":"54","author":"McMahon","year":"2011","journal-title":"Hepatol Baltim Md"},{"issue":"12","key":"10.1016\/j.bulcan.2020.10.014_bib0765","doi-asserted-by":"crossref","first-page":"e1001774","DOI":"10.1371\/journal.pmed.1001774","article-title":"Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial","volume":"11","author":"Qu","year":"2014","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.bulcan.2020.10.014_bib0770","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hep.27048","article-title":"Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8\u00a0million vaccinees","volume":"60","author":"Chien","year":"2014","journal-title":"Hepatol Baltim Md"},{"issue":"3","key":"10.1016\/j.bulcan.2020.10.014_bib0775","doi-asserted-by":"crossref","first-page":"472e1","DOI":"10.1053\/j.gastro.2016.05.048","article-title":"Long-term effects of hepatitis B immunization of infants in preventing liver cancer","volume":"151","author":"Chang","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bulcan.2020.10.014_bib0780","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/add.13944","article-title":"Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs","volume":"113","author":"Palmateer","year":"2018","journal-title":"Addict Abingdon Engl"},{"issue":"2","key":"10.1016\/j.bulcan.2020.10.014_bib0785","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jgh.12063","article-title":"Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?","volume":"28","author":"Winter","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bulcan.2020.10.014_bib0790","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2334-9-86","article-title":"Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy","volume":"9","author":"Scognamiglio","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bulcan.2020.10.014_bib0795","unstructured":"WHO | Global health sector strategy on viral hepatitis 2016-2021 [Internet]. WHO. World Health Organization; [cit\u00e9 24\u00a0avr 2020]. Disponible sur: http:\/\/www.who.int\/hepatitis\/strategy2016-2021\/ghss-hep\/en\/."},{"issue":"12","key":"10.1016\/j.bulcan.2020.10.014_bib0400","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S1473-3099(16)30204-3","article-title":"Requirements for global elimination of hepatitis B: a modelling study","volume":"16","author":"Nayagam","year":"2016","journal-title":"Lancet Infect Dis"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120304914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120304914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:33:45Z","timestamp":1757792025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455120304914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0007455120304914"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.10.014","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination contre le virus de l\u2019h\u00e9patite B et pr\u00e9vention du cancer du foie","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}